Product Monograph
... When discontinuing treatment, patients should be monitored for symptoms which may be associated with discontinuation. The risk of discontinuation symptoms may be dependent on several factors, including the duration and dose of therapy and the rate of dose reduction. Dizziness, sensory disturbances ( ...
... When discontinuing treatment, patients should be monitored for symptoms which may be associated with discontinuation. The risk of discontinuation symptoms may be dependent on several factors, including the duration and dose of therapy and the rate of dose reduction. Dizziness, sensory disturbances ( ...
Mash-Summary-Ibogain..
... addicts in Europe and months. Ibogaine had been administered to opiate and cocaine 9 Althoug h promising, these ...
... addicts in Europe and months. Ibogaine had been administered to opiate and cocaine 9 Althoug h promising, these ...
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES
... processes and within current analytic capabilities. The second aspect is compliance with public standards set by Pharmacopoeias from the three ICH regions (United States Pharmacopoeia (USP), European Pharmacopoeia (Ph. Eur.) and Japanese Phamacopoeia (JP)) and also with local pharmacopoeias from cou ...
... processes and within current analytic capabilities. The second aspect is compliance with public standards set by Pharmacopoeias from the three ICH regions (United States Pharmacopoeia (USP), European Pharmacopoeia (Ph. Eur.) and Japanese Phamacopoeia (JP)) and also with local pharmacopoeias from cou ...
Medication Guide
... Disorder (ADHD) in children 6 years of age and older, adolescents, and adults up to the age of 65 [see Clinical Studies (14)]. A diagnosis of Attention Deficit Hyperactivity Disorder (ADHD; DSM-IV) implies the presence of hyperactive-impulsive or inattentive symptoms that caused impairment and were ...
... Disorder (ADHD) in children 6 years of age and older, adolescents, and adults up to the age of 65 [see Clinical Studies (14)]. A diagnosis of Attention Deficit Hyperactivity Disorder (ADHD; DSM-IV) implies the presence of hyperactive-impulsive or inattentive symptoms that caused impairment and were ...
EXTEMPORANEOUS PREPARATION OF PAEDIATRIC ORAL
... The use of extemporaneous preparations can be considered as unlicensed drug use and these raise concerns about quality, stability, bioavailability, efficacy and safety. Currently, there are no appropriate and comprehensive published standards, and thus decisions in different steps of preparation pro ...
... The use of extemporaneous preparations can be considered as unlicensed drug use and these raise concerns about quality, stability, bioavailability, efficacy and safety. Currently, there are no appropriate and comprehensive published standards, and thus decisions in different steps of preparation pro ...
An Update on Artemisinin- A Multifaceted Drug
... artemisinin class of medications may include transient heart block, nausea, vomiting, anorexia, and dizziness. Mild blood abnormalities have also been noted, rarely allergic reaction. One case of significant liver inflammation has been reported in association with prolonged use of a relatively high ...
... artemisinin class of medications may include transient heart block, nausea, vomiting, anorexia, and dizziness. Mild blood abnormalities have also been noted, rarely allergic reaction. One case of significant liver inflammation has been reported in association with prolonged use of a relatively high ...
Reinforcement, Dopamine and Rodent Models in Drug
... ADHD [34, 37–40]. Other studies have evaluated the effects of different aspects of reinforcement (e.g., delay, frequency, and magnitude) on task performance and response allocation. Recent studies (for more detail see Sonuga-Barke et al. [10]) indicate that children with ADHD show relatively strong ...
... ADHD [34, 37–40]. Other studies have evaluated the effects of different aspects of reinforcement (e.g., delay, frequency, and magnitude) on task performance and response allocation. Recent studies (for more detail see Sonuga-Barke et al. [10]) indicate that children with ADHD show relatively strong ...
The Role of Corticotropin-Releasing Factor in Drug Addiction
... actions of drugs of abuse has largely been driven by three main findings. First, acute administration of drugs of abuse activates the hypothalamic-pituitary-adrenocortical (HPA) stress axis (Sarnyai, 1998), historically the predominant biological marker for stress reactivity (Selye, 1976; McEwen, 19 ...
... actions of drugs of abuse has largely been driven by three main findings. First, acute administration of drugs of abuse activates the hypothalamic-pituitary-adrenocortical (HPA) stress axis (Sarnyai, 1998), historically the predominant biological marker for stress reactivity (Selye, 1976; McEwen, 19 ...
Product Monograph Template - Standard
... When discontinuing treatment, patients should be monitored for symptoms which may be associated with discontinuation. The risk of discontinuation symptoms may be dependent on several factors, including the duration and dose of therapy and the rate of dose reduction. Dizziness, sensory disturbances ( ...
... When discontinuing treatment, patients should be monitored for symptoms which may be associated with discontinuation. The risk of discontinuation symptoms may be dependent on several factors, including the duration and dose of therapy and the rate of dose reduction. Dizziness, sensory disturbances ( ...
Paroxetine
... The recommended dose is 20mg (one tablet) daily. Many patients will respond to a 20mg daily dose. Patients not responding to a 20mg dose may benefit from dose increases in 10mg /day increments, up to a maximum of 50 mg/day according to the patient's response. As with all antidepressant drugs, dosage ...
... The recommended dose is 20mg (one tablet) daily. Many patients will respond to a 20mg daily dose. Patients not responding to a 20mg dose may benefit from dose increases in 10mg /day increments, up to a maximum of 50 mg/day according to the patient's response. As with all antidepressant drugs, dosage ...
Inflammatory lesions of papulopustular rosacea: ivermectin 10 mg/g
... Introduction and current guidance Rosacea is a chronic relapsing disease of the facial skin, characterised by recurrent episodes of facial flushing, persistent erythema, telangiectasia (fine, dilated blood vessels), papules and pustules. Some people have phymatous rosacea with thickening and distort ...
... Introduction and current guidance Rosacea is a chronic relapsing disease of the facial skin, characterised by recurrent episodes of facial flushing, persistent erythema, telangiectasia (fine, dilated blood vessels), papules and pustules. Some people have phymatous rosacea with thickening and distort ...
Technical Guide for countries to set targets for universal
... as prisons. It is important to define the scope of the areas or settings under consideration. While this Technical guide focuses primarily on IDUs, it may also be useful for setting targets for HIV interventions targeting problematic drug users who do not inject but who are at risk of starting to do ...
... as prisons. It is important to define the scope of the areas or settings under consideration. While this Technical guide focuses primarily on IDUs, it may also be useful for setting targets for HIV interventions targeting problematic drug users who do not inject but who are at risk of starting to do ...
CELEXA PM MKT Control 149419 10Jan2012 En
... When discontinuing treatment, patients should be monitored for symptoms which may be associated with discontinuation. The risk of discontinuation symptoms may be dependent on several factors, including the duration and dose of therapy and the rate of dose reduction. Dizziness, sensory disturbances ( ...
... When discontinuing treatment, patients should be monitored for symptoms which may be associated with discontinuation. The risk of discontinuation symptoms may be dependent on several factors, including the duration and dose of therapy and the rate of dose reduction. Dizziness, sensory disturbances ( ...
GMC Guidelines for Buprenorphine- Naloxone
... • Buprenorphine-naloxone is a partial opioid agonist that is approved for treatment of opioid dependence or severe opioid use disorders (ICD-10 code: F11.10 or F11.20). • YOU MUST HAVE A SPECIAL X-license in order to prescribe buprenorphine-naloxone. In accordance with federal statute, the Drug Addi ...
... • Buprenorphine-naloxone is a partial opioid agonist that is approved for treatment of opioid dependence or severe opioid use disorders (ICD-10 code: F11.10 or F11.20). • YOU MUST HAVE A SPECIAL X-license in order to prescribe buprenorphine-naloxone. In accordance with federal statute, the Drug Addi ...
Steady-state bioequivalence studies of two memantine tablet and
... the mean concentration vs time profiles showed double and triple concentration maxima (Fig. 2). We found that the intra-individual and interindividual variability in the proposed characteristics of bioequivalence (AUC0 τ,ss and Cmax,ss) was low (less than 13% and 18%, respectively). The composite me ...
... the mean concentration vs time profiles showed double and triple concentration maxima (Fig. 2). We found that the intra-individual and interindividual variability in the proposed characteristics of bioequivalence (AUC0 τ,ss and Cmax,ss) was low (less than 13% and 18%, respectively). The composite me ...
SEIKO ABUBAKARI - Kwame Nkrumah University of Science
... Malaria is a public health problem worldwide, especially in tropical Africa where it kills around a million of people a year, of which 75% are children under 5 years of age, drug assessment in this group is lower which complicate the choice of appropriate treatment. Quinine is re-emerging as an impo ...
... Malaria is a public health problem worldwide, especially in tropical Africa where it kills around a million of people a year, of which 75% are children under 5 years of age, drug assessment in this group is lower which complicate the choice of appropriate treatment. Quinine is re-emerging as an impo ...
Assessing the Public Health Impacts of Legalizing Recreational
... of survey data that take into account preexisting differences between states with and those without medical marijuana laws in cannabis use and social attitudes towards cannabis use. Harper et al.36 applied this method of analysis to the data used by Wall et al.35 They found no differences in rates o ...
... of survey data that take into account preexisting differences between states with and those without medical marijuana laws in cannabis use and social attitudes towards cannabis use. Harper et al.36 applied this method of analysis to the data used by Wall et al.35 They found no differences in rates o ...
Doctoral Thesis
... very optimistic without justification that bacterial infections were controlled sufficiently and they would be eradicated. Unhappily, the inappropriate use of antibiotics and chemotherapeutics was very frequent. During next years, many bacterial species have developed a resistance to widely applied ...
... very optimistic without justification that bacterial infections were controlled sufficiently and they would be eradicated. Unhappily, the inappropriate use of antibiotics and chemotherapeutics was very frequent. During next years, many bacterial species have developed a resistance to widely applied ...
Long-acting Beta-Agonists with and without Inhaled Corticosteroids and Catastrophic Asthma Events
... this meta-analysis are based on a relatively small number of events, so they should be interpreted with caution. However, these findings provide evidence that long-acting -agonists are associated with significant risk, even when used with concomitant inhaled corticosteroids. This is the first meta- ...
... this meta-analysis are based on a relatively small number of events, so they should be interpreted with caution. However, these findings provide evidence that long-acting -agonists are associated with significant risk, even when used with concomitant inhaled corticosteroids. This is the first meta- ...
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS)
... Drugs increase the volume or decrease the viscosity of respiratory secretions, facilitate their removal by ciliary action and coughing. 1.1Mucolytic expectorants: Drugs alter chemical characteristics of sputum to decrease its viscosity and to facilitate its removal by ciliary action or coughing. eg. ...
... Drugs increase the volume or decrease the viscosity of respiratory secretions, facilitate their removal by ciliary action and coughing. 1.1Mucolytic expectorants: Drugs alter chemical characteristics of sputum to decrease its viscosity and to facilitate its removal by ciliary action or coughing. eg. ...
The role of drug metabolism in drug discovery and
... University of Oulu, P.O. Box 8000, FI-90014 University of Oulu, Finland ...
... University of Oulu, P.O. Box 8000, FI-90014 University of Oulu, Finland ...
Combined use of ECT and psychotropic drugs
... of medications during ECT treatment. Nowadays more often not only the safety of such procedure, but also possibility of synergistic therapeutic effect of ECT and psychopharmacology is highlighted. The authors present previous reports on combined use of pharmacotherapy and ECT, safety or potential ri ...
... of medications during ECT treatment. Nowadays more often not only the safety of such procedure, but also possibility of synergistic therapeutic effect of ECT and psychopharmacology is highlighted. The authors present previous reports on combined use of pharmacotherapy and ECT, safety or potential ri ...
Polysubstance dependence
A person with polysubstance dependence is psychologically addicted to being in an intoxicated state without a preference for one particular substance. Although any combination of three drugs can be used, studies have shown that alcohol is commonly used with another substance. This is supported by one study on polysubstance use that separated participants who used multiple substances into groups based on their preferred drug. The three substances were cocaine, alcohol, and heroin, which implies that those three are very popular. Other studies have found that opiates, cannabis, amphetamines, hallucinogens, inhalants and benzodiazepines are often used in combination as well. The results of a long-term or longitudinal study on substance use led the researchers to observe that excessively using or relying on one drug increased the probability of excessively using or relying on another drug.